Timothy P. Search, RPh
Legislation & Regulation
John Carroll
Compared to the existing state of affairs, there’s a lot to like in mandatory coverage, but the Massachusetts experiment is a lesson to not expect miracles
Medication Management
Martin Sipkoff
A recently announced initiative is supposed to speed approval of generic drugs, but does it address some fundamental flaws in the approval process?
Tomorrow's Medicine
Thomas Morrow, MD
As the use of biomarkers grows, managed care companies will face tough decisions about setting limits
Plan Watch
Frank Diamond
Regence’s effort gets nod of approval from physician organization because it allows providers to respond
News and Commentary